Publications

Oral Presentation

Genome Engineered Hematopoietic Transplants for the Treatment of AML

March 10, 2025

Keystone Symposia – 2025 – Oral Presentation

Read More

Poster Presentation

Multiplex Genome Engineering Strategies to Enable Next-Generation Shielded HSPC Transplants for Treatment of Acute Myeloid Leukemia

March 10, 2025

Keystone Symposia – 2025 – Poster Presentation 2033

Read More

Oral Presentation

A CD33-Deleted Allograft (Trem-cel) Enables Post-Hematopoietic Cell Transplant (HCT) Maintenance Dosing of Gemtuzumab Ozogamicin (GO) with Therapeutic Levels of Drug Exposure and Low Hematologic and Hepatic Toxicity in Patients with High-Risk Acute Myeloid Leukemia (AML)

February 15, 2025

Tandem Meetings – 2025 – Encore Oral Presentation

Read More

Poster Presentation

Understanding the Patient Experience and Potential Barriers to Enrollment and Participation in Cell and Gene Therapy (CGT) Trials in Acute Myeloid Leukemia (AML)

February 13, 2025

Tandem Meetings – 2025 – Poster Presentation 503

Read More

Poster Presentation

A CD33-Deleted Allograft (Trem-cel) Enables Post-Hematopoietic Cell Transplant (HCT) Maintenance Dosing of Gemtuzumab Ozogamicin (GO) with Therapeutic Levels of Drug Exposure and Low Hematologic and Hepatic Toxicity in Patients with High-Risk Acute Myeloid Leukemia (AML)

December 8, 2024

ASH – 2024 – Poster Presentation 2873

Read More

Poster Presentation

Multimodal atlas of paired diagnosis and relapse AML reveals surface antigens for multi-specific immunotherapy

December 7, 2024

ASH – 2024 – Poster Presentation 1558

Read More

Poster Presentation

Leveraging CRISPR/Cas9 and HDR to create an engineered CD33 CAR-T to treat AML

November 7, 2024

SITC – 2024 – Poster Presentation 1092

Read More

Oral Presentation

Novel CD33/CLL-1-directed dual CAR-T cells mediate potent antigen-specific cytolytic activity in mouse models of Acute Myeloid Leukemia (AML)

October 24, 2024

ESGCT – 2024 – Oral Presentation OR085

Read More

Oral Presentation

Analyzing Guide RNA (gRNA) Impurity Discovery & Quantification

September 18, 2024

CRISPR-Based Therapy Analytical Development Summit – Oral Presentation

Read More

Load More